Business Standard

Worldwide drug sales to hit $ 1.06 trillion in 2022: Study

Pricing pressure to cause drug sales forecasts to fall for first time in 10 years, says Evaluate

Capsules
Premium

Capsules

BS B2B Bureau London, UK
Increased scrutiny around the pricing of medicines is starting to have an impact on drug sales growth, according to Evaluate’s latest World Preview report. Despite consensus forecasts for worldwide drug sales hitting $ 1.06 trillion in 2022, this is down from the $ 1.12 trillion analysts forecast for the same period last year.

The fall also represents the first time in 10 years of Evaluate analysis that total drug sales have failed to beat previous year forecasts.

However, sales of some of the industry’s hottest products such as cancer immunotherapies (ie, Keytruda and Opdivo) are expected to help propel the sector to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in